HLS THERAPEUTICS INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.94 CAD | +0.25% |
|
-17.40% | -0.25% |
| 05-09 | Transcript : HLS Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
| 05-09 | HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HLS THERAPEUTICS INC. | Pharmaceuticals Wholesale | +0.25% | -17.40% | -0.25% | -14.90% | -76.58% | 91.82M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- HLS Stock
- Charts HLS Therapeutics Inc.
- Comparison Chart